Christopher J Coughlin Alexion Pharmaceuticals, Inc. (ALXN) insider trading activity

Christopher J Coughlin is Director of ALEXION PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ALXN, which is worth approximately $0. The most recent transaction as insider was on Jul 21, 2021, when has been sold 42,347 shares (Common Stock, par value $.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

CHRISTOPHER J COUGHLIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jul 21 2021	SELL Sale (or disposition) back to the issuer	-	42,347 Reduced 100.0%	0 Common Stock, par valu...
May 20 2021	BUY Grant, award, or other acquisition	-	2,691 Added 5.97%	42,347 Common Stock, par valu...

Also insider at

CNC

CENTENE CORP Healthcare

Director

KRTX

Karuna Therapeutics, Inc. Healthcare

PBH

Prestige Consumer Healthcare Inc. Healthcare

Director

CJC